A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.

Source:http://linkedlifedata.com/resource/pubmed/id/16028147

Clin. Infect. Dis. 2005 Aug 15 41 4 425-32

Download in:

View as

Triples

General Info

PMID
16028147